These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29960167)

  • 1. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.
    Kang K; Gao Y; Wang SC; Liu HT; Kong WL; Zhang X; Huang R; Qi ZD; Zheng JB; Qu JD; Liu RJ; Liu YS; Wang HL; Yu KJ
    Biomed Pharmacother; 2018 Oct; 106():210-216. PubMed ID: 29960167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy.
    Yu T; Liu D; Gao M; Yang P; Zhang M; Song F; Zhang X; Liu Y
    Biomed Pharmacother; 2019 Dec; 120():109231. PubMed ID: 31546082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway.
    Liu Z; Wang Y; Wang Y; Ning Q; Zhang Y; Gong C; Zhao W; Jing G; Wang Q
    Int Immunopharmacol; 2016 Jun; 35():210-216. PubMed ID: 27074053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Renal-Splenic Axis Involvement in Acute Kidney Injury Mediated by the α7nAChR-NF-κB Signaling Pathway.
    Gao Y; Kang K; Liu YS; Li NN; Han QY; Liu HT; Kong WL; Zhang X; Huang R; Yang ZY; Qi ZD; Zheng JB; Li M; Wang HL; Li JY; Liu RJ; Wang SC; Zhang WH; Zhao MY; Yu KJ
    Inflammation; 2021 Apr; 44(2):746-757. PubMed ID: 33141376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
    Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
    Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
    Zi SF; Li JH; Liu L; Deng C; Ao X; Chen DD; Wu SZ
    Int Immunopharmacol; 2019 Nov; 76():105898. PubMed ID: 31520992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
    Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
    Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
    Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
    J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
    Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
    Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
    Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
    Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice.
    Liu Y; Yu Y; Zhang J; Wang C
    Life Sci; 2019 Dec; 239():116868. PubMed ID: 31682847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.
    Wang Z; Wu J; Hu Z; Luo C; Wang P; Zhang Y; Li H
    Oxid Med Cell Longev; 2020; 2020():5454210. PubMed ID: 33194004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the α7nAChR by GTS-21 mitigates septic tubular cell injury and modulates macrophage infiltration.
    Yang A; Wu CH; Matsuo S; Umene R; Nakamura Y; Inoue T
    Int Immunopharmacol; 2024 Sep; 138():112555. PubMed ID: 38943973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
    Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
    Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
    Xiang H; Hu B; Li Z; Li J
    Inflammation; 2014 Oct; 37(5):1763-70. PubMed ID: 24803295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
    Li Q; Chen C; Chen X; Han M; Li J
    Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine alleviates cisplatin‑induced acute kidney injury by attenuating endoplasmic reticulum stress‑induced apoptosis via the α2AR/PI3K/AKT pathway.
    Chai Y; Zhu K; Li C; Wang X; Shen J; Yong F; Jia H
    Mol Med Rep; 2020 Mar; 21(3):1597-1605. PubMed ID: 32016445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine attenuates ferroptosis by Keap1-Nrf2/HO-1 pathway in LPS-induced acute kidney injury.
    Luo RR; Yang J; Sun YL; Zhou BY; Zhou SX; Zhang GX; Yang AX
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7785-7796. PubMed ID: 38722344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
    Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury.
    Uchida A; Kidokoro K; Sogawa Y; Itano S; Nagasu H; Satoh M; Sasaki T; Kashihara N
    Nephrology (Carlton); 2019 Jan; 24(1):28-38. PubMed ID: 29068550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.